Stock UR9 CLINUVEL PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Clinuvel Pharmaceuticals Limited Deutsche Boerse AG

Equities

UR9

AU000000CUV3

Market Closed - Deutsche Boerse AG
Other stock markets
 07:14:18 17/05/2024 BST 		5-day change 1st Jan Change
9.385 EUR +1.90% Intraday chart for Clinuvel Pharmaceuticals Limited +2.34% -5.43%
04-29 Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% MT
03-14 Clinuvel Pharmaceuticals Launches Share Buyback Program MT

Evolution of the average Target Price on Clinuvel Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

a271c8c036467dcc1fd3ed07b5580.fPpXduyB9QXtZdCicN1ukhPG0pMajVhQZ1ZtKR8RQDk.RaMOPtywuTO8IafDFYUa9yqzuN8uymEJXj4yfitLIlgLrg4GmNC2XZsfmQ~92af2c6bc8e445f3e14cb7e83eadf94c

Analyst Recommendations on Clinuvel Pharmaceuticals Limited

Morgans Financial Upgrades Clinuvel Pharmaceuticals to Add From Hold; Price Target is AU$16 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
15.45 AUD
Average target price
25.6 AUD
Spread / Average Target
+65.71%
High Price Target
46.3 AUD
Spread / Highest target
+199.68%
Low Price Target
16 AUD
Spread / Lowest Target
+3.56%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Clinuvel Pharmaceuticals Limited

Morgans Financial

Ratings for Clinuvel Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CUV Stock
  4. UR9 Stock
  5. Consensus Clinuvel Pharmaceuticals Limited